- Trials with a EudraCT protocol (31,658)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
31,658 result(s) found for: 0.
Displaying page 1,171 of 1,583.
| EudraCT Number: 2009-011790-32 | Sponsor Protocol Number: 09.0111p | Start Date*: 2010-03-18 |
| Sponsor Name:Isala Klinieken Department Cardiology | ||
| Full Title: Catheter ablation versus Amiodarone to prevent future shock episodes in patients with a defibrillator and a history of a myocardial infarction. | ||
| Medical condition: The main objective of this study is to compare the occurrence of next ICD shock therapy for VT or VF in patients with hospital presentation for an ICD shock therapy for VT or VF, with a history of ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019863-12 | Sponsor Protocol Number: Mouvements | Start Date*: Information not available in EudraCT |
| Sponsor Name:Paris Descartes - Laboratoire Psychologie Clinique et Psychopathologie | ||
| Full Title: Analyse du mouvement rythmique spontané, mesure de la cohérence cardiaque et appréciation des conduites cliniques et langagières chez des enfants hyperactifs en situation d'examen psychométrique et... | ||
| Medical condition: Motor control and activities régulation attention's capacities | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015529-35 | Sponsor Protocol Number: 0918703 | Start Date*: 2009-12-04 | |||||||||||
| Sponsor Name:CHU TOULOUSE | |||||||||||||
| Full Title: Prise en charge pharmacologique de l’anxiété et de la douleur chez les patients qui souffrent en situation d’urgence traumatique préhospitalière : étude randomisée contrôlée en double-aveugle. | |||||||||||||
| Medical condition: douleur en situation d’urgence traumatique préhospitalière | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-017468-18 | Sponsor Protocol Number: CS/IV-RMF-01 | Start Date*: 2010-07-02 | |||||||||||
| Sponsor Name:Bioibérica S.A. | |||||||||||||
| Full Title: Ensayo clínico aleatorizado, doble ciego, controlado con placebo para valorar el efecto de condroitín sulfato sobre el dolor en pacientes afectos de artrosis de rodilla mediante Resonancia Magnétic... | |||||||||||||
| Medical condition: Knee osteoarthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-021738-72 | Sponsor Protocol Number: GEMCAD1003 | Start Date*: 2010-10-27 |
| Sponsor Name:GEMCAD | ||
| Full Title: Estudio fase II abierto, no aleatorizado, para evaluar la eficacia y seguridad del tratamiento neoadyuvante concomitante de Gemcitabina y Erlotinib seguido de Gemcitabina, Erlotinib y radioterapia ... | ||
| Medical condition: Adenocarcinoma de páncreas resecable | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-016140-39 | Sponsor Protocol Number: IDI-GAD-2009-01 | Start Date*: 2010-01-19 |
| Sponsor Name:Institut Diagnostic per la Imatge | ||
| Full Title: MRI in Clinically Isolated Syndromes and relapsing multiple sclerosis after single dose (0.1 mmol/kg) and cumulative dose (0.1 + 0.1 mmol/kg) of GADOVIST at 3.0T Estudio de resonancia magnética 3... | ||
| Medical condition: Realce de contraste en resonancia magnética en pacientes con Síndrome Clínico Aislado o recaída de Esclerosis Múltiple con resonancia magnética anormal anterior después de la administración de dosi... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-003341-32 | Sponsor Protocol Number: MSC-GVHD1 | Start Date*: 2008-06-26 |
| Sponsor Name:University medical Center Utrecht | ||
| Full Title: Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stem cells expanded with human plasma and platelet lysate ; a phase I/II study | ||
| Medical condition: MSCs may be useful for treating established severe GVHD after stem cell transplantation. Preliminary data on 40 patients with steroid refractory grade III-IV acute GvHD were recently presented (K L... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019541-26 | Sponsor Protocol Number: P091102 | Start Date*: 2010-05-14 |
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
| Full Title: Protocole pilote d'étude de l'efficacité et de la sécurité d'un traitement de l'allergie à l'arachide par immunothérapie épicutanée (EPIT) chez des enfants allergiques : étude multicentrique random... | ||
| Medical condition: Enfants allergiques à l'arachide. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001959-37 | Sponsor Protocol Number: E7449-E044-101 | Start Date*: 2011-10-17 | |||||||||||||||||||||||||||||||
| Sponsor Name:Eisai Limited | |||||||||||||||||||||||||||||||||
| Full Title: An open label, multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects with Advanced Solid Tumours or with B-cell Malignancies and in Combinat... | |||||||||||||||||||||||||||||||||
| Medical condition: Advanced solid tumors (including ovarian cancer, triple negative breast cancer, and advanced melanoma) and B-cell lymphomas | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2010-023536-16 | Sponsor Protocol Number: ITN043AD | Start Date*: 2011-02-25 |
| Sponsor Name:University of California, San Francisco, Immune Tolerance Network | ||
| Full Title: A Randomised, Double-blind, Single-centre, Placebo controlled Study of Sublingual Immunotherapy and Subcutaneous Immunotherapy in Adults with Seasonal Allergic Rhinitis (ITN043AD) | ||
| Medical condition: Grass-pollen induced rhinoconjunctivitis (hay fever). | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002968-24 | Sponsor Protocol Number: NN2211-3916 | Start Date*: 2012-04-20 | |||||||||||
| Sponsor Name:Novo Nordisk A/S | |||||||||||||
| Full Title: Efficacy and safety of liraglutide versus placebo as add-on to existing diabetes medication in subjects with type 2 diabetes and moderate renal impairment | |||||||||||||
| Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-005784-24 | Sponsor Protocol Number: MEIXO-VALV-001 | Start Date*: 2012-06-14 |
| Sponsor Name:Andres Iñiguez Romo | ||
| Full Title: Dual antiplatelet therapy versus oral anticoagulation for a short time to prevent cerebral embolism after percutaneous aortic valve implantation. Multicenter randomized clinical trial. | ||
| Medical condition: Evaluate the efficacy of dual antiplatelet therapy versus oral anticoagulation for primary prevention of cerebral thromboembolism at three months after percutaneous aortic valve implantation (TAVI). | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-000281-23 | Sponsor Protocol Number: Oxford University(None) | Start Date*: 2009-09-10 | ||||||||||||||||
| Sponsor Name:University of Oxford | ||||||||||||||||||
| Full Title: Melatonin in Acute Mania Investigation (MIAMI-UK) | ||||||||||||||||||
| Medical condition: Bipolar Disorder (mania and hypomania) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2012-001151-39 | Sponsor Protocol Number: A1501081 | Start Date*: 2012-03-06 |
| Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017 | ||
| Full Title: An Open Label, Intravenous to Oral Switch, Multiple Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Immunocompromised Adolescents Aged 12 to <17 Years who ar... | ||
| Medical condition: Invasive fungal infections | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2012-001171-37 | Sponsor Protocol Number: 20021626 | Start Date*: 2012-03-07 |
| Sponsor Name:Amgen, Inc. One Amgen Center Drive Thousand Oaks, California 91320 | ||
| Full Title: A Phase IV Registry of Etanercept in Children With Juvenile Rheumatoid Arthritis | ||
| Medical condition: Juvenile idiopathic arthritis (JIA) | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002363-15 | Sponsor Protocol Number: ML27901 | Start Date*: 2011-08-17 | |||||||||||
| Sponsor Name:Roche a/s | |||||||||||||
| Full Title: Multicenter, randomized, parallel group study to compare the incidence of Tocilizumab related infusion reactions in patients with moderate to severe active RA, when infusion is given over 31 minute... | |||||||||||||
| Medical condition: Adult Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IS (Completed) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-002081-20 | Sponsor Protocol Number: 2010_52 | Start Date*: 2013-05-13 |
| Sponsor Name:CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE | ||
| Full Title: A Multicenter Open label Phase II study of Pomalidomide and Dexamethasone in Progressive Relapsed or Refractory Multiple Myeloma patients with deletion 17p or translocation (4;14) Adverse Karyotypi... | ||
| Medical condition: This study will determine the efficacy and toxicity profile of pomalidomide and dexamethasone in patients with adverse prognostic factors as determined using adverse karyotypic abnormalities and th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000933-37 | Sponsor Protocol Number: CRT113890 | Start Date*: 2012-09-18 |
| Sponsor Name:National and Kapodostrian University of Athens | ||
| Full Title: Phase II trial of ofatumumab combined with ESHAP as salvage therapy before autologous stem cell transplantation, for patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) previ... | ||
| Medical condition: Relapsed or refractory diffuse large B cell lymphoma (DLBCL). | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003602-25 | Sponsor Protocol Number: CBEZ235B2203 | Start Date*: 2011-12-13 | |||||||||||
| Sponsor Name:Novartis Farmaceutica S.A. | |||||||||||||
| Full Title: Estudio fase Ib/fase II aleatorizado, de BEZ235 y trastuzumab frente a lapatinib y capecitabina, en pacientes con cáncer de mama metastásico o localmente avanzado HER2 positivo, que no han respondi... | |||||||||||||
| Medical condition: Adult female patients with HER2 positive locally advanced or metastatic breast cancer who received prior trastuzumab treatment. Phase II: patients must have additionally received prior taxane thera... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: ES (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-006250-90 | Sponsor Protocol Number: EARL-2 | Start Date*: 2012-07-11 |
| Sponsor Name:EANM Forschungs GmbH / EANM Research Ltd. | ||
| Full Title: Randomized double-blind placebo controlled Phase II study to evaluate the efficacy and safety of Sorafenib treatment in patients with advanced (recurrent, persistent and/or metastasizing) medullary... | ||
| Medical condition: Advanced (recurrent, persistent and/or metastasizing) medullary thyroid carcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) AT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
